A Comparison of Study Designs of Inhaled Agents in Non-Cystic Fibrosis Bronchiectasis (NCFB): Key Differences in the Phase 3 RESPIRE Trials of Ciprofloxacin Dry Powder for Inhalation (DPI)

被引：0
|
作者：
Aksamit, Timothy [1 ]
De Soyza, Anthony [1 ]
Operschall, Elisabeth [1 ]
Bandel, Tiemo-Joerg [1 ]
Wilson, Robert [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CHEST | 2015年 / 148卷 / 04期
关键词：
D O I：
10.1378/chest.2277297
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
662A
引用
收藏
页数：2
相关论文
共 39 条
  • [21] Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study To Evaluate The Safety And Efficacy Of Ciprofloxacin Dry Powder For Inhalation (Ciprofloxacin DPI) Compared With Placebo In Patients With Non-Cystic Fibrosis Bronchiectasis
    Wilson, R.
    Welte, T.
    Polverino, E.
    De Soyza, A.
    Greville, H.
    O'Donnell, A.
    Alder, J.
    Reimnitz, P.
    Hampel, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [22] Inhaled Dry Powder Antibiotics in Patients with Non-Cystic Fibrosis Bronchiectasis: Efficacy and Safety in a Real-Life Study
    Angel Martinez-Garcia, Miguel
    Oscullo, Grace
    Barreiro, Esther
    Cuenca, Selene
    Cervera, Angela
    Padilla-Galo, Alicia
    de la Rosa, David
    Navarro, Annie
    Giron, Rosa
    Carbonero, Francisco
    Castro Otero, Maria
    Casas, Francisco
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07)
  • [23] Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients
    Hoppentocht, Marcel
    Akkerman, Onno W.
    Hagedoorn, Paul
    Alffenaar, Jan-Willem C.
    van der Werf, Tjip S.
    Kerstjens, Huib A. M.
    Frijlink, Henderik W.
    de Boer, Anne H.
    PLOS ONE, 2016, 11 (03):
  • [24] Lung Deposition Of Ciprofloxacin Dry Powder For Inhalation In Healthy Subjects And Patients Suffering From Chronic Obstructive Pulmonary Disease Or Non-Cystic Fibrosis Bronchiectasis
    Stass, H.
    Nagelschmitz, J.
    Kappeler, D.
    Weimann, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [25] Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers (vol 30, pg 53, 2017)
    Stass, Heino
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (06) : 451 - 451
  • [26] Respire 2: Ciprofloxacin Dpi 32.5 Mg B.i.d. Administered 14 Days On/off Or 28 Days On/off Vs. Placebo For 48 Weeks In Patients With Non-Cystic Fibrosis Bronchiectasis (ncfb)
    Aksamit, T. R.
    Bandel, T. -J.
    Criollo, M.
    Elborn, J.
    Lau, M.
    Operschall, E.
    Polverino, E.
    Montegriffo, E.
    De Soyza, A.
    Winthrop, K. L.
    Wilson, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INHALED CIPROFLOXACIN COMPARED WITH PLACEBO IN PATIENTS WITH CYSTIC FIBROSIS - A PHASE IIB STUDY OF CIPROFLOXACIN DRY POWDER FOR INHALATION (DPI)
    Dorkin, H.
    Criollo, M.
    Reimnitz, P.
    Alder, J.
    Hampel, B.
    PEDIATRIC PULMONOLOGY, 2011, : 296 - 296
  • [28] Impact Of Baseline Pseudomonas AerugINOSa (psa) Presence On Outcomes In A Phase Ii Clinical Trial Of Ciprofloxacin Dpi In Patients With Non-Cystic Fibrosis Bronchiectasis
    Wilson, R.
    Operschall, E.
    Roth, K.
    Bandel, T. -J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [29] LATE-BREAKING ABSTRACT: RESPIRE 1: Ciprofloxacin DPI 32.5mg b.d. administered 14 day on/off or 28 day on/off vs placebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB)
    De Soyza, Anthony
    Aksamit, Timothy
    Bandel, Tiemo-Joerg
    Criollo, Margarita
    Elborn, J. Stuart
    Krahn, Ulrike
    Operschall, Elisabeth
    Polverino, Eva
    Winthrop, Kevin
    Wilson, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [30] Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections
    O'Donnell, Anne
    Froehlich, Juergen
    Thompson, Bruce
    Dahms, Janice
    Cipolla, David
    Davis, Angela
    Gonda, Igor
    Haworth, Charles
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
1234